Close Menu

NEW YORK (GenomeWeb) – Thermo Fisher Scientific said last week that it has entered into a 364-day unsecured term loan facility in the principal amount of $1.5 billion.

The company may use the proceeds of the loans to help fund the acquisition of Patheon, which is estimated to be approximately $7.2 billion in total. This includes repayment of Patheon's debt and transaction costs incurred in connection with the acquisition.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.